These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2549457)

  • 1. New glycosylpeptides with high antinociceptive activity.
    Rodriguez RE; Rodriguez FD; Sacristán MP; Torres JL; Valencia G; Garcia Antón JM
    Neurosci Lett; 1989 Jun; 101(1):89-94. PubMed ID: 2549457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive activity of glycosidic enkephalin analogues.
    Rodríguez RE; Rodríguez FD; Sacristán MP; Torres JL; Reig F; García Antón JM; Valencia G
    Psychopharmacology (Berl); 1990; 101(2):222-5. PubMed ID: 2349363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supraspinal antinociception produced by [D-Met2]-FMRFamide in mice.
    Raffa RB; Connelly CD
    Neuropeptides; 1992 Jul; 22(3):195-203. PubMed ID: 1331846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C; Jhamandas K; Sutak M; Zajac JM
    Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enkephalin derivative, cyclo[Nepsilon,Nbeta-carbonyl-D-Lys2, Dap5] enkephalinamide (cUENK6), induces a highly potent antinociception in rats.
    Kotlinska J; Bochenski M; Lagowska-Lenard M; Gibula-Bruzda E; Witkowska E; Izdebski J
    Neuropeptides; 2009 Jun; 43(3):221-8. PubMed ID: 19376576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of spinal opioid antinociception by intrathecal beta-endorphin1-27 in the rat.
    Hong M; Sutak M; Jhamandas K
    Br J Pharmacol; 1993 Apr; 108(4):1137-42. PubMed ID: 8485623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1982 Jul; 222(1):190-7. PubMed ID: 7201020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. kappa-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat.
    Leighton GE; Rodriguez RE; Hill RG; Hughes J
    Br J Pharmacol; 1988 Mar; 93(3):553-60. PubMed ID: 2836010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.
    Miglécz E; Székely JI; Dunai-Kovács Z
    Psychopharmacology (Berl); 1979 Mar; 62(1):29-34. PubMed ID: 108745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective modulation of morphine antinociception, but not development of tolerance, by delta receptor agonists.
    Jiang Q; Mosberg HI; Porreca F
    Eur J Pharmacol; 1990 Sep; 186(1):137-41. PubMed ID: 2178093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of antinociceptive and motor effects of supraspinal opioid agonists in the rat.
    Franck LS; Miaskowski C; Putris J; Levine JD
    Brain Res; 1991 Nov; 563(1-2):123-6. PubMed ID: 1664771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
    Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F
    Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
    Tiseo PJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1988 Aug; 246(2):449-53. PubMed ID: 2900324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
    Miaskowski C; Levine JD
    Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
    Jhamandas KH; Sutak M; Henderson G
    Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
    J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.
    Qi JA; Mosberg HI; Porreca F
    Life Sci; 1990; 47(11):PL43-7. PubMed ID: 2170791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.